Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection
D Nie, Y Hu, Z Chen, M Li, Z Hou, X Luo, X Mao… - Journal of biomedical …, 2020 - Springer
Acinetobacter baumannii (A. baumannii) is an important opportunistic pathogen causing
serious nosocomial infections, which is considered as the most threatening Gram-negative …
serious nosocomial infections, which is considered as the most threatening Gram-negative …
The Outer Membrane Proteins OmpA, CarO, and OprD of Acinetobacter baumannii Confer a Two-Pronged Defense in Facilitating Its Success as a Potent Human …
Of all the ESKAPE pathogens, carbapenem-resistant and multidrug-resistant Acinetobacter
baumannii is the leading cause of hospital-acquired and ventilator-associated pneumonia …
baumannii is the leading cause of hospital-acquired and ventilator-associated pneumonia …
Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It
Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten
public health. The formidable adaptability and resistance of this opportunistic pathogen have …
public health. The formidable adaptability and resistance of this opportunistic pathogen have …
Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections
Background With the increasing rate of antibiotic resistance in Acinetobacter, the World
Health Organization introduced the carbapenem-resistant isolates in the priority pathogens …
Health Organization introduced the carbapenem-resistant isolates in the priority pathogens …
Vaccine development to control the rising scourge of antibiotic-resistant Acinetobacter baumannii: a systematic review
Acinetobacter baumannii has emerged as one of major nosocomial pathogen and global
emergence of multidrug-resistant strains has become a challenge for developing effective …
emergence of multidrug-resistant strains has become a challenge for developing effective …
Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection
Acinetobacter baumannii is a serious health threat with a high mortality rate. We have
already reported prophylactic effects of IgYs raised against OmpA and Omp34 as well as …
already reported prophylactic effects of IgYs raised against OmpA and Omp34 as well as …
BauA and Omp34 surface loops trigger protective antibodies against Acinetobacter baumannii in a murine sepsis model
Z Akbari, I Rasooli, MH Ghaini, S Chaudhuri… - International …, 2022 - Elsevier
The complexity of treating Acinetobacter baumannii infections with the newly developed
resistant strains has led researchers to confront this pathogen by developing vaccines. In …
resistant strains has led researchers to confront this pathogen by developing vaccines. In …
[HTML][HTML] Reverse vaccinology approach for the identifications of potential vaccine candidates against Salmonella
J Li, J Qiu, Z Huang, T Liu, J Pan, Q Zhang… - International Journal of …, 2021 - Elsevier
Salmonella is a leading cause of foodborne pathogen which causes intestinal and systemic
diseases across the world. Vaccination is the most effective protection against Salmonella …
diseases across the world. Vaccination is the most effective protection against Salmonella …
Outer Membrane Protein, Oma87 Prevents Acinetobacter baumannii Infection
Acinetobacter baumannii is one of the most problematic pathogens in clinical settings.
Emerging of its antibiotic-resistant strains persuade researchers to find alternative treatment …
Emerging of its antibiotic-resistant strains persuade researchers to find alternative treatment …
Combination of BauA and OmpA elicit immunoprotection against Acinetobacter baumannii in a murine sepsis model
Aims Acinetobacter baumannii causes severe nosocomial infections and is a difficult-to-treat
pathogen due to the development of multidrug-resistant (MDR) strains. Vaccines and …
pathogen due to the development of multidrug-resistant (MDR) strains. Vaccines and …